PLGA Carriers for Controlled Release of Levofloxacin in Anti-Tuberculosis Therapy
Levofloxacin (LFX) is a highly effective anti-tuberculosis drug with a pronounced bactericidal activity against <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>). In this work, an "organic solvent-free" approach has been used for the development of polylactic-co-glycol...
Saved in:
Main Authors: | Evgeny N. Antonov (Author), Sofya N. Andreevskaya (Author), Irina V. Bocharova (Author), Sergei E. Bogorodsky (Author), Larisa I. Krotova (Author), Elena E. Larionova (Author), Alexandra O. Mariyanats (Author), Gennady V. Mishakov (Author), Tatiana G. Smirnova (Author), Larisa N. Chernousova (Author), Vladimir K. Popov (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PLGA: The smart therapeutics goods carrier
by: Dr. Radhika J Poojari
Published: (2013) -
PLGA Based Drug Carrier and Pharmaceutical Applications
Published: (2021) -
HPLC determination, pharmacokinetics and relative bioavailability of levofloxacin produced by «OZONE», Russia
by: S. N. Kondratenko, et al.
Published: (2013) -
Magnesium Orotate Influence on Thoracic Aorta in Laboratory Rabbits Receiving Levofloxacin
by: N. V. Izmozherova, et al.
Published: (2024) -
PLGA Based Drug Carrier and Pharmaceutical Applications: The Most Recent Advances
by: Joana Angélica Loureiro, et al.
Published: (2020)